abstract |
The present disclosure relates broadly to antiviral compounds, and more specifically to the function of NS3 protease encoded by hepatitis C virus (HCV) (also referred to herein as “serine protease”). Compounds that inhibit, compositions comprising such compounds, and methods of inhibiting the function of NS3 protease. |